Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Using Once Every Other Week Subcutaneous Administration of Aranesp™ (Darbepoetin Alfa) and Iron Guided Algorithms to Treat Subjects With Anemia of Chronic Renal Insufficiency (CRI)

NCT00368901 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00368901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00368901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Using Once Every Other Week Subcutaneous Administration of Aranesp™ (Darbepoetin Alfa) and Iron Guided Algorithms to Treat Subjects With Anemia of Chronic Renal Insufficiency (CRI)
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2002
Completion date
May 31, 2004
Enrollment
618 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic renal insufficiency, kidney disease, pre-dialysis, pre-esrd